Age, comorbidities, ADL score, tumor size, positive lymph nodes, HR status, HER-2 status, and Ki-67 were meaningfully associated with chemotherapy in univariate analysis, and at multivariate analysis, age and ADL score remained significant, along with comorbidities, tumor size, positive lymph nodes, and HR status. The gene discussed is ERBB2; the disease is neoplasm.